No beneficial effects, but severe side effects caused by recombinant human tissue plasminogen activator for treatment of hepatic veno-occlusive disease after allogeneic bone marrow transplantation - Hagglund,H.; Ringden,O.; Ljungman,P. (Transplant Proc, 1995)